StockTipsArenaBeta

Piramal Pharma Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹191.19-3.25 (-1.67%)
As of 21 Oct 2026

Avg 1-year target

All 5 long-term calls are BUY

₹24528.1% above today's price

Piramal Pharma's average 1-year share price target is ₹245, the average of 4 advisors' latest targets. Targets range from ₹235 to ₹250.

Latest: Nirav Chheda, Nirmal Bang Securities ₹250 · 24 Sept 2026

7
7 BUY · 0 SELL, all horizons
4
with an active 1Y target
55%
26 of 47 closed calls hit
54
all horizons, open and closed
Watch PPLPHARMA for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Piramal Pharma target price by brokerage

Each advisor's latest 1-year target · 4 advisors · tap a row for the call

All tips (54)

BUYTarget₹250
NCbyNirav Chheda, Nirmal Bang Securities+30.8% to target
1 Year* · 11 mo left · 24 Sept 2026 · entry ₹208.99 · via CNBC Awaaz.P&L -8.5%
BUYTarget₹250
GSbyGoldman Sachs+30.8% to target
1 Year* · 11 mo left · 24 Sept 2026 · entry ₹210.65 · via Zee Business (Live)P&L -9.2%
BUYTarget₹235
JIbyJefferies India+22.9% to target
1 Year* · 10 mo left · 27 Aug 2026 · entry ₹212.19 · via Financial Express MarketP&L -9.9%
BUYTarget₹245
ISbyICICI Securities+28.1% to target
1 Year* · 9 mo left · 31 Jul 2026 · entry ₹196.72 · via Institutional / Brokerage ResearchP&L -2.8%
BUYTarget₹240
ISbyICICI Securities+25.5% to target
1 Year* · 9 mo left · 30 Jul 2026 · entry ₹196.72 · via Institutional / Brokerage ResearchP&L -2.8%
BUYTarget₹230
MObyMotilal OswalTarget hit
1 Year* · 30 Jul 2026 · entry ₹196.72 · via Institutional / Brokerage Researchexit ₹230
BUYTarget₹200
JIbyJefferies IndiaTarget hit
1 Year* · 28 Jul 2026 · entry ₹191.75 · via CNBC Awaaz.exit ₹200
BUYTarget₹220
ISbyICICI SecuritiesTarget hit
1 Year* · 30 Apr 2026 · entry ₹161.87 · via Institutional / Brokerage Researchexit ₹220
BUYTarget₹230
ISbyICICI SecuritiesTarget hit
1 Year* · 30 Jan 2026 · entry ₹154.68 · via Institutional / Brokerage Researchexit ₹230
BUYTarget₹190
MObyMotilal OswalTarget hit
1 Year* · 29 Jan 2026 · entry ₹153.69 · via Institutional / Brokerage Researchexit ₹190
BUYTarget₹280
ISbyICICI SecuritiesTarget hit
1 Year* · 25 Sept 2024 · entry ₹226.31 · via Institutional / Brokerage Researchexit ₹280
BUYTarget₹260
MObyMotilal OswalTarget hit
1 Year* · 25 Sept 2024 · entry ₹226.31 · via Institutional / Brokerage Researchexit ₹260
BUYTarget₹230
ISbyICICI SecuritiesTarget hit
1 Year* · 12 Aug 2024 · entry ₹185.84 · via Institutional / Brokerage Researchexit ₹230
BUYTarget₹200
ISbyICICI SecuritiesTarget hit
1 Year* · 28 Jul 2024 · entry ₹166.51 · via Institutional / Brokerage Researchexit ₹200
BUYTarget₹210
ISbyICICI SecuritiesTarget hit
1 Year* · 22 Jul 2024 · entry ₹151.42 · via Institutional / Brokerage Researchexit ₹210
BUYTarget₹248
VbyVenturaTarget hit
1 Year* · 4 Jun 2024 · entry ₹144.8 · via Institutional / Brokerage Researchexit ₹248
BUYTarget₹176
HSbyHem SecuritiesTarget hit
1 Year* · 20 May 2024 · entry ₹149.5 · via Institutional / Brokerage Researchexit ₹176
BUYTarget₹209
NWbyNuvama WealthTarget hit
1 Year* · 14 May 2024 · entry ₹148.9 · via Institutional / Brokerage Researchexit ₹209
BUYTarget₹190
ISbyICICI SecuritiesTarget hit
1 Year* · 13 May 2024 · entry ₹154.2 · via Institutional / Brokerage Researchexit ₹190
BUYTarget₹190
MObyMotilal OswalTarget hit
1 Year* · 13 May 2024 · entry ₹154.2 · via Institutional / Brokerage Researchexit ₹190
BUYTarget₹150
NWbyNuvama WealthTarget hit
1 Year* · 4 Feb 2024 · entry ₹137.65 · via Institutional / Brokerage Researchexit ₹150
BUYTarget₹240
MObyMotilal OswalExpired
1 Year* · 29 Jul 2025 · entry ₹205.61 · via Institutional / Brokerage Researchexit ₹195.68
BUYTarget₹265
ISbyICICI SecuritiesExpired
1 Year* · 29 Jul 2025 · entry ₹205.61 · via Institutional / Brokerage Researchexit ₹195.68
BUYTarget₹250
MObyMotilal OswalExpired
1 Year* · 15 May 2025 · entry ₹208.61 · via Institutional / Brokerage Researchexit ₹174.87
BUYTarget₹283
NWbyNuvama WealthExpired
1 Year* · 30 Jan 2025 · entry ₹231.25 · via Institutional / Brokerage Researchexit ₹154.68
BUYTarget₹310
MObyMotilal OswalExpired
1 Year* · 24 Oct 2024 · entry ₹255.84 · via Institutional / Brokerage Researchexit ₹202.37
BUYTarget₹268
RKbyRachit Khandelwal+40.2% to target
1–3 Months · 5 wk left · 26 Aug 2026 · entry ₹212.3 · via Business TodayP&L -9.9%
BUYTarget₹235
RJbyRuchit Jain, Motilal Oswal+22.9% to target
1–3 Months* · 2 wk left · 6 Aug 2026 · entry ₹208.93 · via Business TodayP&L -8.5%
BUYTarget₹220
OKbyOsho Krishan, Angel OneTarget hit
1–3 Months* · 3 Aug 2026 · entry ₹201.75 · via Business Todayexit ₹220
BUYTarget₹218
OKbyOsho Krishan, Angel OneTarget hit
1–3 Months* · 3 Aug 2026 · entry ₹201.85 · via Business Todayexit ₹218
BUYTarget₹230
SUbySacchitanand Uttekar, Tradebulls SecuritiesStop-loss hit
1–3 Months* · 22 Sept 2026 · entry ₹210.9 · via Zee Business (Live)exit ₹209
BUYTarget₹196
ICbyIDBI CapitalStop-loss hit
1–3 Months* · 3 Jul 2026 · entry ₹176.6 · via IDBI Capital Research Calls Telegramexit ₹168.2
BUYTarget₹240
AJbyAnshul Jain, Lakshmishree Investment and SecuritiesExpired
1–3 Months · 27 May 2026 · entry ₹175.71 · via Business Todayexit ₹211.29
BUYTarget₹230
DMbyDeven Mehata, IDBI Capital Markets and SecuritiesTarget hit
1–2 Weeks* · 28 Aug 2026 · entry ₹214.95 · via NDTV Profit (Live)exit ₹230
BUYTarget₹230
ICbyIDBI CapitalTarget hit
1–2 Weeks* · 27 Aug 2026 · entry ₹215 · via IDBI Capital Research Calls Telegramexit ₹230
BUYTarget₹217
MBbyMadhu BansalTarget hit
1–2 Weeks* · 30 Jul 2026 · entry ₹199.37 · via CNBC Awaaz.exit ₹217
BUYTarget₹210
RPbyRajesh Palviya, Axis SecuritiesTarget hit
1–2 Weeks* · 30 Jul 2026 · entry ₹194.99 · via Business Todayexit ₹210
BUYTarget₹206
RBbyRakesh BansalTarget hit
1–2 Weeks · 30 Jul 2026 · entry ₹195.68 · via Zee Business (Live)exit ₹206
BUYTarget₹210
NCbyNirav Chheda, Nirmal Bang SecuritiesTarget hit
1–2 Weeks* · 28 Jul 2026 · entry ₹193.38 · via CNBC Awaaz.exit ₹210
BUYTarget₹190
DSbyDharmesh Shah, ICICI SecuritiesTarget hit
1–2 Weeks* · 20 Jul 2026 · entry ₹176.5 · via LiveMint Marketsexit ₹190
BUYTarget₹188.5
ICbyIDBI CapitalTarget hit
1–2 Weeks* · 16 Jul 2026 · entry ₹176.45 · via IDBI Capital Research Calls Telegramexit ₹188.5
BUYTarget₹230
SRbySiddharth Rai MangalaStop-loss hit
1–2 Weeks* · 21 Sept 2026 · entry ₹215.6 · via Zee Business (Live)exit ₹209
BUYTarget₹219
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 21 Sept 2026 · entry ₹211 · via IDBI Capital Research Calls Telegramexit ₹207
BUYTarget₹236
AKbyArun Kumar MantriStop-loss hit
1–2 Weeks · 8 Sept 2026 · entry ₹227 · via CNBC Awaaz.exit ₹221
BUYTarget₹245
KSbyKshitija Salvi, Globe Capital MarketStop-loss hit
1–2 Weeks* · 7 Sept 2026 · entry ₹219.82 · via CNBC Awaaz.exit ₹213
BUYTarget₹250
PHbyPradip Hotchandani, Prudent Corporate Advisory ServicesStop-loss hit
1–2 Weeks* · 28 Aug 2026 · entry ₹218.76 · via CNBC Awaaz.exit ₹211
BUYTarget₹223
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 20 Aug 2026 · entry ₹213 · via IDBI Capital Research Calls Telegramexit ₹208
BUYTarget₹193
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 21 Jul 2026 · entry ₹183 · via IDBI Capital Research Calls Telegramexit ₹178
BUYTarget₹195
SMbySomil Mehta, SharekhanStop-loss hit
1–2 Weeks* · 3 Jul 2026 · entry ₹176.6 · via CNBC Awaaz.exit ₹168
BUYTarget₹195
RDbyRupak De, LKP SecuritiesStop-loss hit
1–2 Weeks* · 3 Jul 2026 · entry ₹178.4 · via Zee Business (Live)exit ₹171

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Full call history, all horizons: page 2 of 2

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks